MDLZ's stock price is currently trading at $64.51, with a recent high of $64.7 and a low of $63.7. The stock has shown a slight upward trend in the last trading session, closing at $64.51, representing a 0.88% increase. The Relative Strength Index (RSI) for MDLZ is 52.73, indicating a neutral position, neither overbought nor oversold. The MACD line is slightly above the signal line, suggesting a weak bullish signal.
The Fibonacci levels for MDLZ indicate a pivot point at $66.43. The first resistance level is at $69.15, and the first support level is at $63.71. The stock is currently trading near the lower end of its recent range, suggesting potential support around the $63.71 level.
Recent analyst ratings indicate a Moderate Buy consensus, with an average price target of $67.63. Bernstein maintains a Buy rating with a price target of $81.00, while other analysts have lowered their targets due to concerns over cocoa prices and margins.
Based on the current technical indicators, Fibonacci levels, and analyst sentiment, MDLZ is expected to trade between $63.71 and $69.15 in the next trading week. The stock is likely to face resistance at the Fibonacci pivot point of $66.43.
Given the current price of $64.51 and the potential upside to the pivot point, it is recommended to buy MDLZ with a target price of $65.00. The stock is near a support level, and the bullish MACD signal, combined with the Moderate Buy consensus, suggests a potential short-term upside.
The price of MDLZ is predicted to go up 7.88%, based on the high correlation periods with BTT. The similarity of these two price pattern on the periods is 96.99%.
MDLZ
BTT
Mondelez's strategic shift to empower in-market leaders and fuel investments in its local jewels (which had historically been starved in favor of its global brands) stands to incite growth in emerging markets for some time.
We posit the firm is laser-focused on removing inefficiencies from its operations and will likely maintain an eye toward shedding noncore stock-keeping units to reduce complexity.
Management has emphatically suggested it won't sacrifice profit gains merely to inflate its near-term sales profile, which we view as prudent.
Piper Sandler
2025-02-05
Price Target
$63 → $56
Downside
-2.49%
Piper Sandler
2025-01-31
Price Target
$70 → $63
Upside
+8.64%
Stifel
2025-01-24
Price Target
$82 → $70
Upside
+21.91%